Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The latest evidence, however, suggests that as clinical use of GLP-1 drugs expands for both obesity and diabetes, it is imperative that treatment guidelines address not only initiation and titration but also discontinuation and long-term maintenance strategies to sustain therapeutic gains. Clinicians say the findings carry particularly significant implications for younger patients, who may wish or need to stop these medications after achieving desired weight-loss outcomes
& McNabb-Baltar, J
J.CannonJ
If you have any queries or need any help, please contact us at [email protected]
PubMed laboratory research record [PMID: 12904603] PubMed record related to this compound for laboratory literature review
